Geneticist Jack Szostak Shares Nobel Prize in Physiology or Medicine

Jack W. Szostak, a geneticist at Harvard Medical School, is one of three co-winners of the 2009 prize.

Jack Szostak

Professor of genetics Jack W. Szostak has won the Nobel Prize in Physiology or Medicine with Elizabeth H. Blackburn (University of California, San Francisco) and Carol W. Greider (Johns Hopkins School of Medicine). The three scientists were recognized for their work on how chromosomes are protected by telomeres and the enzyme telomerase. Szostak's home page at Harvard Medical School details his recent work on the synthesis of life on earth: "the related challenges of understanding the origin of life on the early earth, and constructing synthetic cellular life in the laboratory." His lab home page is here; he is also a Howard Hughes Medical Institute investigator, and  has a biographical page there, emphasizing his current work on the origins of life and the re-creation of the first steps in biological synthesis. Harvard's Origins of Life Initiative is described here; Szostak is one of the affiliated faculty members.

According to the Nobel press release, the trio have solved a critical part of a fundamental problem in biology: "how the chromosomes can be copied in a complete way during cell divisions and how they are protected against degradation. The Nobel Laureates have shown that the solution is to be found in the ends of the chromosomes--the telomeres--and in an enzyme that forms them – telomerase."


The explanation continues:

The long, thread-like DNA molecules that carry our genes are packed into chromosomes, the telomeres being the caps on their ends. Elizabeth Blackburn and Jack Szostak discovered that a unique DNA sequence in the telomeres protects the chromosomes from degradation. Carol Greider and Elizabeth Blackburn identified telomerase, the enzyme that makes telomere DNA. These discoveries explained how the ends of the chromosomes are protected by the telomeres and that they are built by telomerase.


If the telomeres are shortened, cells age. Conversely, if telomerase activity is high, telomere length is maintained, and cellular senescence is delayed. This is the case in cancer cells, which can be considered to have eternal life. Certain inherited diseases, in contrast, are characterized by a defective telomerase, resulting in damaged cells. The award of the Nobel Prize recognizes the discovery of a fundamental mechanism in the cell, a discovery that has stimulated the development of new therapeutic strategies.

 

Related topics

You might also like

Harvard Adopts Reforms as Higher Ed Turmoil Continues

University creates new “interfaith engagement” role; Columbia, Brown settle with the government.

“Do You Find That Reasonable?” Harvard Undergraduates Discuss a Changing University

A student panel grapples—civilly—with shifting policies and differing opinions.

Remembering Tom Lehrer

The mathematician and satirist kept Harvard in his thoughts—and lyrics.

Most popular

The Professor Who Quantified Democracy

Erica Chenoweth’s data shows how—and when—authoritarians fall.

Harvard Layoffs Continue, with More to Come

In the wake of federal government actions, several Harvard schools and institutes are cutting costs.

The Downsides of Prozac

Harvard researchers discuss the side effects of Prozac and other SSRIs

Explore More From Current Issue

Grid of headshots showing newly elected Harvard Overseers and Directors, with names and titles listed below each photo.

Alumni showed increased interest in this year’s elections.

David Souter

Remembering David Souter ’61, LL.B. ’66

A computer bank, hovering ove a city, with electric wires coming out from the bottom and attaching themselfs into the city

Utilities shift AI infrastructure costs onto consumers.